Akari Therapeutics Releases Virtual Investor “What This Means” Segment
Akari Therapeutics Releases Virtual Investor “What This Means” Segment GlobeNewswire December 18, 2025 Watch the “What This Means” video here TAMPA, Fla. and LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and CEO of […]